Advertisement
Screener

NIGHTSTAR THERAPEUTICS PLC Comprehensive Income

NIGHTSTAR THERAPEUTICS PLC Comprehensive Income

NIGHTSTAR THERAPEUTICS PLC reported Comprehensive Income of -$17.65 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-10.

Discontinued › Income Statement › Unrealized Gains

us-gaap:ComprehensiveIncomeNetOfTax · last filed 2019-05-10

  • NIGHTSTAR THERAPEUTICS PLC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-03-31 was -$17.65M.
  • NIGHTSTAR THERAPEUTICS PLC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2018-12-31 was -$12.39M.
  • NIGHTSTAR THERAPEUTICS PLC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2018-09-30 was -$10.35M.
  • NIGHTSTAR THERAPEUTICS PLC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2018-06-30 was -$10.78M.
  • NIGHTSTAR THERAPEUTICS PLC comprehensive income (loss), net of tax, attributable to parent for fiscal 2018 was -$41.53M.
  • NIGHTSTAR THERAPEUTICS PLC comprehensive income (loss), net of tax, attributable to parent for fiscal 2017 was -$25.70M.
  • NIGHTSTAR THERAPEUTICS PLC comprehensive income (loss), net of tax, attributable to parent for fiscal 2016 was -$13.58M.
Period endComprehensive Income (Loss), Net of Tax, Attributable to Parent 3 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 6 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 9 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month
2019-03-31-$17.65M
10-Q · filed 2019-05-10
-$30.04M
derived: sum of 2 quarters · filed 2019-05-10
-$40.39M
derived: sum of 3 quarters · filed 2019-05-10
-$51.16M
derived: sum of 4 quarters · filed 2019-05-10
2018-12-31-$12.39M
derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18
-$22.74M
derived: sum of 2 quarters · filed 2019-03-18
-$33.51M
derived: sum of 3 quarters · filed 2019-03-18
-$41.53M
10-K · filed 2019-03-18
2018-09-30-$10.35M
6-K · filed 2018-11-20
-$21.13M
derived: sum of 2 quarters · filed 2018-11-20
-$29.14M
6-K · filed 2018-11-20
-$42.50M
derived: sum of 4 quarters · filed 2019-05-10
2018-06-30-$10.78M
6-K · filed 2018-08-15
-$18.79M
6-K · filed 2018-08-15
-$32.15M
derived: sum of 3 quarters · filed 2019-05-10
-$38.52M
derived: sum of 4 quarters · filed 2019-05-10
2018-03-31-$8.01M
10-Q · filed 2019-05-10
-$21.38M
derived: sum of 2 quarters · filed 2019-05-10
-$27.74M
derived: sum of 3 quarters · filed 2019-05-10
-$30.38M
derived: sum of 4 quarters · filed 2019-05-10
2017-12-31-$13.36M
derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18
-$19.73M
derived: sum of 2 quarters · filed 2019-03-18
-$22.37M
derived: sum of 3 quarters · filed 2019-03-18
-$25.70M
10-K · filed 2019-03-18
2017-09-30-$6.36M
6-K · filed 2018-11-20
-$9.01M
derived: sum of 2 quarters · filed 2018-11-20
-$12.33M
6-K · filed 2018-11-20
2017-06-30-$2.64M
6-K · filed 2018-08-15
-$5.97M
6-K · filed 2018-08-15
2016-12-31-$13.58M
10-K · filed 2019-03-18
2015-12-31-$14.19M
20-F · filed 2018-04-03